DIFABIO ANDREA (Chief Legal Officer) sold 34.8% of their position (2.61K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $156.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0001193125-26-102667
Officer· Chief Legal Officer
Since Mar 2026
+4.89K
Net shares
Net buyer
$156.7K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
15K acquired · 10.11K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+7.50K
Price / share
—
Trade value
—
% of position
New position
3/9/2026
0.00→7.50K
Common Shares
Direct
Shares
−2.61K
Price / share
$60.11
Trade value
$156.70K
% of position
34.8%
3/10/2026
7.50K→4.89K
Total
Net shares
+4.89K
Net value
-$156.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/9/2026 | M · Option Exercise | +7.50K | — | — | New position | 0.00 | 7.50K |
| Common Shares Direct | 3/10/2026 | S · Sale | −2.61K | $60.11 | $156.70K | 34.8% | 7.50K | 4.89K |
| Total | +4.89K | -$156.70K | ||||||
Derivative Transactions2
Performance Share Units
Direct
Converts to
Common Shares
7.50K shares
Shares
+7.50K
Strike price
Held after
7.50K
Exercisable
—
3/9/2026
Performance Share Units
Direct
Converts to
Common Shares
7.50K shares
Shares
−7.50K
Strike price
Held after
0.00
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Share Units Direct | Common Shares7.50K shares | 3/9/2026 | A · Award | +7.50K | — | 7.50K | |
| Performance Share Units Direct | Common Shares7.50K shares | 3/9/2026 | M · Option Exercise | −7.50K | — | 0.00 |